Tryptophan Injection

Generic Name:

L-Tryptophan (administered IV only as part of amino-acid solutions used for parenteral nutrition)

Pharmacological Class:

Essential aromatic amino acid; precursor to serotonin, melatonin, niacin, and kynurenine pathway metabolites.

Clinical Use:

Provided intravenously to prevent or treat tryptophan deficiency in patients unable to receive enteral nutrition, including:

• Critically ill patients requiring Total Parenteral Nutrition (TPN)
• Major surgery, trauma, burns
• Severe malabsorption
• Prolonged NPO status
• Short bowel syndrome

Rationale:

Tryptophan is required for:

• Protein synthesis
• Neurotransmitter synthesis (serotonin)
• Immune function
• Maintenance of nitrogen balance
• Production of niacin via the kynurenine pathway

Important:

Tryptophan is not dosed individually as an IV injection. It is supplied only within balanced PN amino-acid solutions.
Therefore dosing is based on total amino acid requirement, not tryptophan alone.

Adult Parenteral Nutrition Requirements (General):

• Typical PN amino-acid dose: 8–1.5 g/kg/day
• Higher needs in burns, trauma, catabolic illness: up to 0–2.5 g/kg/day

Within standard PN solutions, tryptophan content is ~1–1.4% of total amino acids.

Approximate Delivered Tryptophan (from standard AA solutions):

• 13–20 mg/kg/day (approximate; varies by manufacturer)

Method of Administration:

• Administer only as part of continuous IV infusion via central or peripheral PN protocols.
• Never administer IV tryptophan as a bolus or standalone infusion.

Individualized Dosing:

Requires consideration of:

• Renal/hepatic function
• Nitrogen balance goals
• Metabolic rate and catabolism
• Electrolyte status
• Fluid restrictions

Precise dosing must be calculated by a licensed prescriber within a medically supervised nutrition-support program.

Protein & Tissue Synthesis

• Tryptophan is an essential amino acid incorporated into structural proteins, enzymes, and hormones.
• Supports muscle protein synthesis, wound healing, and nitrogen balance.

Serotonin Synthesis

Tryptophan → 5-Hydroxytryptophan (5-HTP) → Serotonin (5-HT)
Roles:

• Modulation of mood
• Gastrointestinal motility
• Platelet aggregation
• Sleep regulation

Melatonin Synthesis

Serotonin → N-Acetyl serotonin → Melatonin
Supports circadian rhythm and sleep physiology.

Niacin (Vitamin B3) Production

Tryptophan → Kynurenine → Niacin
Contributes to NAD/NADP synthesis, essential for cellular energy metabolism.

Kynurenine Pathway Functions

• Immune regulation
• Neuroprotection and neuroinflammation balance
• Modulation of oxidative stress pathways

Immune System

Tryptophan availability affects:

• T-cell proliferation
• IDO (indoleamine 2,3-dioxygenase) activity

Inflammatory cytokine regulation

Absolute Contraindications

• Known hypersensitivity to any component of amino-acid PN solutions
• Inborn errors of amino-acid metabolism
• Severe hepatic encephalopathy (risk of elevated aromatic amino acids)
• Acute shock or severe hemodynamic instability (relative contraindication to PN)

Relative Contraindications & Conditions Requiring Caution

• Renal impairment (risk of azotemia if protein load excessive)
• Pre-existing serotonin syndrome risk (e.g., patient taking serotonergic medication)
• Uncontrolled sepsis (nutritional support may need adjustment)
• Severe metabolic acidosis
• Hypertryptophanemia disorders (rare)

Clinical Monitoring Required

• Serum electrolytes
• Renal/liver function
• Triglycerides (if PN contains lipids)
• Ammonia levels (especially in hepatic dysfunction)
• Blood glucose
• Nitrogen balance

Pharmacologic Interactions

Serotonergic drugs:

• SSRIs, SNRIs, MAOIs, tricyclic antidepressants
• Tramadol
• Linezolid
• MDMA
• 5-HTP supplements

→ Excess tryptophan availability may elevate serotonin levels and increase the risk of serotonin syndrome, though this is rare with PN-level dosing.

Corticosteroids:

• Can enhance protein breakdown → alters amino-acid utilization.

Levodopa:

• Competition at transport sites may reduce levodopa uptake (clinically mild during PN).

B. Laboratory Interference

• May influence serotonin and kynurenine measurements.
• Can alter tryptophan/large neutral amino acid ratio, affecting neurotransmitter synthesis studies.

Adverse Reactions / Side Effects

Because tryptophan is not given alone, adverse effects reflect total PN formulation and patient metabolic state.

Common (Mild)

• Nausea
• Vomiting
• Headache
• Gastrointestinal discomfort (from metabolic effects of PN)

Metabolic Effects

• Hyperammonemia (especially in hepatic insufficiency)
• Elevated BUN/creatinine
• Electrolyte disturbances
• Hyperglycemia (from PN carbohydrates)

Neurological Effects

• Sedation, somnolence (rare)
• Agitation or confusion if serotonin levels shift (rare)

Serious / Rare

• Serotonin syndrome (primarily when concurrent SSRIs/SNRIs/MAOIs used)
• Allergic or anaphylactoid reactions to PN components
• Infection or thrombosis related to central venous catheter
• Refeeding syndrome (phosphate, magnesium, potassium shifts

Pregnancy

• Tryptophan is a normal part of protein metabolism and is considered safe when administered as part of medically indicated PN.
• PN use in pregnancy should be carefully monitored due to metabolic demands and fluid balance.

Breastfeeding

• Tryptophan is naturally present in breast milk.
• PN containing tryptophan is generally acceptable during lactation if clinically necessary.
• Monitor infants for unusual sedation only as a precaution.

Storage Conditions for Amino-Acid PN Solutions Containing Tryptophan

• Store between 20–25°C (68–77°F).
• Protect from excessive heat or freezing.
• Keep in original packaging until use.
• If added to a PN admixture:
  • Refrigerate at 2–8°C.
  • Use within 24 hours of preparation once removed from refrigeration.

Compatibility

• Compatible with most PN ingredients (lipids, electrolytes, vitamins) following manufacturer guidelines.
• Follow institution-specific PN compounding and stability standards.

• ASPEN (American Society for Parenteral and Enteral Nutrition) Clinical Guidelines for Parenteral Nutrition.
• ESPEN Guidelines on Parenteral Nutrition in Intensive Care.
• Young VR. “Adult amino acid requirements: implications for parenteral nutrition.” Clin Nutr.
• Fernstrom JD. “Tryptophan metabolism and brain function.” J Nutr.
• Parenteral Nutrition Handbook – ASHP.
• Manufacturer labeling for commercial amino-acid injection products (e.g., Aminosyn®, Clinisol®, Primene®).
• Wurtman RJ, Fernstrom M. “Control of brain monoamine synthesis by precursor availability.” Am J Clin Nutr.
• Calder PC, et al. “Proteins and amino acids in nutrition support.”